Satsuma Pharmaceuticals Inc. buy BiotechBee
Start price
08.09.22
/
50%
€6.30
Target price
31.12.24
€8.00
Performance (%)
-88.33%
End price
14.12.22
€0.74
Summary
This prediction ended on 14.12.22 with a price of €0.74. Massive losses of -88.33% were the result for the BUY prediction by BiotechBee. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Satsuma Pharmaceuticals Inc. | - | - | - |
iShares Core DAX® | 2.831% | 1.236% | 14.788% |
iShares Nasdaq 100 | 2.918% | 0.640% | 40.290% |
iShares Nikkei 225® | 2.007% | -2.135% | 19.861% |
iShares S&P 500 | 2.257% | 0.451% | 30.090% |
According to BiotechBee what are the pros and cons of Satsuma Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Satsuma Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 8,0
In the thread Trading Satsuma Pharmaceuticals Inc.
Buy beendet